AU2001285287A1 - Use of sublethal concentrations of anti-invasin compounds to therapeutically or prophylactically treat fungal infections - Google Patents

Use of sublethal concentrations of anti-invasin compounds to therapeutically or prophylactically treat fungal infections

Info

Publication number
AU2001285287A1
AU2001285287A1 AU2001285287A AU8528701A AU2001285287A1 AU 2001285287 A1 AU2001285287 A1 AU 2001285287A1 AU 2001285287 A AU2001285287 A AU 2001285287A AU 8528701 A AU8528701 A AU 8528701A AU 2001285287 A1 AU2001285287 A1 AU 2001285287A1
Authority
AU
Australia
Prior art keywords
invasin
therapeutically
compounds
fungal infections
prophylactically treat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001285287A
Inventor
Brian Cali
Etchell Cordero
Peter Hecht
G. Todd Milne
Sofie Salama
Eric F. Summers
Joshua Trueheart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microbia Inc
Original Assignee
Microbia Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microbia Inc filed Critical Microbia Inc
Publication of AU2001285287A1 publication Critical patent/AU2001285287A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001285287A 2000-08-25 2001-08-27 Use of sublethal concentrations of anti-invasin compounds to therapeutically or prophylactically treat fungal infections Abandoned AU2001285287A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64971100A 2000-08-25 2000-08-25
US09/649,711 2000-08-25
PCT/US2001/026598 WO2002015897A2 (en) 2000-08-25 2001-08-27 Use of sublethal concentrations of anti-invasin compounds to therapeutically or prophylactically treat fungal infections

Publications (1)

Publication Number Publication Date
AU2001285287A1 true AU2001285287A1 (en) 2002-03-04

Family

ID=24605924

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001285287A Abandoned AU2001285287A1 (en) 2000-08-25 2001-08-27 Use of sublethal concentrations of anti-invasin compounds to therapeutically or prophylactically treat fungal infections

Country Status (3)

Country Link
US (1) US7291720B2 (en)
AU (1) AU2001285287A1 (en)
WO (1) WO2002015897A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10045123B8 (en) * 2000-09-13 2008-01-24 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. The C. albicans TEC1 GEN (CaTEC1) and the encoded Tec1p protein
US7488757B2 (en) * 2003-03-24 2009-02-10 Becton, Dickinson And Company Invisible antimicrobial glove and hand antiseptic
WO2006036817A2 (en) * 2004-09-24 2006-04-06 Microbia, Inc. Fungal variants and uses thereof
CA2489194A1 (en) * 2004-12-03 2006-06-03 Guilhem Janbon Polypeptides involved in candida biofilm formation and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5833946A (en) 1995-06-06 1998-11-10 Bayer Corporation Dissemination of fungal infections: animal model and method of prophylaxis

Also Published As

Publication number Publication date
US7291720B2 (en) 2007-11-06
WO2002015897A2 (en) 2002-02-28
US20030176367A1 (en) 2003-09-18
WO2002015897A3 (en) 2003-12-24

Similar Documents

Publication Publication Date Title
AU2003247617A1 (en) Topical administration of basic antifungal compositions to treat fungal infections of the nails
AU2002230471A1 (en) Surface preparation prior to deposition
WO2002060879A3 (en) Bacterial gyrase inhibitors and uses thereof
AU2001255779A1 (en) Topical preparation for the treatment of hair loss
AU2001266068A1 (en) Treatment of mineral substrates
AU2001294515A1 (en) Use of stat-6 inhibitors as therapeutic agents
AU2001272852A1 (en) Composition for the treatment of migraine
AU2001281852A1 (en) Highly concentrated stable meloxicam solutions
AUPQ877300A0 (en) Topical treatment of skin
AU2002325026A1 (en) Use of neuraminidase inhibitors to prevent flu associated bacterial infections
MXPA01009951A (en) Composition to enhance permeation of topical skin agents.
AU2002232558A1 (en) Compounds, compositions and methods for treatment of parasitic infections
AU2002364964A1 (en) Galliumcomplexes of 3-hydroxy-4-pyrones to treat mycobacterial infections
AU2001272383A1 (en) Fungicidal combinations of active agents
PL365072A1 (en) Azole compounds as therapeutic agents for fungal infections
AU2001266486A1 (en) New compounds useful as antibacterial agents
AU2001285287A1 (en) Use of sublethal concentrations of anti-invasin compounds to therapeutically or prophylactically treat fungal infections
AU2001231173A1 (en) Laulimalide compounds as microtubule stabilizing agents
AUPQ629000A0 (en) Inhibition of fungi
AU2002228660A1 (en) Use of amidoamines to treat or prevent acanthamoeba and fungal infections
AU2002214976A1 (en) Process for the preparation of benzotriazoles
AU2001258598A1 (en) Use of metal compounds to treat gastrointestinal infections
AU2002236116A1 (en) Method to treat soapy wastewater
AU2001262148A1 (en) Use of 3-iodine-2-propinyl-carbamates as antimicrobial active agent
WO2001066115A3 (en) Acetylsalicylic acid solutions